Synthego company logo
Synthego
Actively Hiring
Use engineered cells to make better project decisions and avoid the laborious editing process51-200 Employees
  • B2B
  • Scale Stage
    Rapidly increasing operations
  • Top Investors
    This company has received a significant amount of investment from top investors
  • 4.2
    Highly rated
    Synthego is highly rated on Glassdoor, with 4.2 out of 5 stars
Website
Location
Company size
51-200 people
Total raised
$161.6M
Company type
StartupBiotech
Markets
BiotechnologySynthetic BiologyIndustrial AutomationSoftwareInnovation ManagementInnovation EngineeringGenetic Testing

Synthego careers

Use engineered cells to make better project decisions and avoid the laborious editing process
Synthego’s vision is to turn biology into an information science, with the ultimate goal of dramatically extending the healthy human lifespan.

Synthego builds advanced bioinformatics and automated hardware platforms to create next-generation molecular biology tools, starting with full-stack genome engineering.

These world-class tools accelerate basic scientific discovery, critical disease cures and novel synthetic biology applications to improve and prolong life.
2 weeks ago
2 weeks ago
4 weeks ago
1 month ago
Michael Dabrowski
Avatar for Michael Dabrowski
Founder at @Synthego; Previously: CEO @Interave Media; CTO @TradeHill; Head of Software Dev @Halcyon Molecular; Head of Software Dev @SpaceX; @UIUC @UCSD Alumn
Paul Dabrowski
Avatar for Paul Dabrowski
Founder at @Synthego, @Interave Media. Lead engineer of P4 Electron Microscope at @Halcyon Molecular. Lead Digital Designer at @SpaceX. MS Computer Engineering
Total raised

$161.6M

Funded over

6 rounds

Latest round

Feb 2019

Medical, dental & vision

Equity

Free meals

Transportation

Green environment

+3 more